Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
See a half-lit moon shine among the stars of Aquarius on Nov. 27 - 2There was a bit of toilet trouble on NASA's Artemis 2 mission to the moon
- 3Evaluated Smartwatches for Wellness Devotees
- 4UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- 5Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
- Activists guilty over Palestine protest breach
- Yes, NASA's launching Artemis 2 astronauts to the moon on April Fools' Day. It's not a joke.
- Iran fires one of largest barrages in weeks ahead of Passover
- Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- How did I get my own unique set of fingerprints?
- The Best Internet based Retailers for Style and Frill
- Jason Kelce opens about wife Kylie Kelce's past pregnancy loss
